How an Electronic Version of EDSS Improves Data Quality in MS Trials
Signant Health
Aug 10, 2021

Signant collaborated with research teams at University Hospital Basel to adapt the Neurostatus-EDSS scale for electronic administration.
Widely used for primary endpoint measurement in multiple sclerosis clinical trials, the eEDSS was designed to address common challenges:
✅ Eliminate scoring variability with standardized electronic administration
✅ Reduce errors and missing data for higher-quality results
✅ Streamline workflows for faster, more efficient reviews
In this case study, learn how our eEDSS solution helped the study teams optimize data quality, reduce timelines, as well as burdens on sites and participants in three MS trials.